FITC anti-mouse CD45 Antibody

Pricing & Availability
Clone
30-F11 (See other available formats)
Regulatory Status
RUO
Other Names
T200, Ly-5, LCA
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
30-f11
C57BL/6 splenocytes stained with 30-F11 FITC
  • 30-f11
    C57BL/6 splenocytes stained with 30-F11 FITC
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
103107 50 µg $36
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103108 500 µg $105
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45 is a 180-240 kD glycoprotein also known as the leukocyte common antigen (LCA), T200, or Ly-5. It is a member of the protein tyrosine phosphatase (PTP) family, expressed on all hematopoietic cells except mature erythrocytes and platelets. There are different isoforms of CD45 that arise from variable splicing of exons 4, 5, and 6, which encode A, B, and C determinants, respectively. CD45 plays a key role in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation state of the cell as well as cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone 30-F11 reacts with all isoforms and both CD45.1 and CD45.2 alloantigens of CD45.

Additional reported applications (for relevant formats) include: immunoprecipitation3, complement-dependent cytotoxicity1,5, immunohistochemistry (acetone-fixed frozen sections, zinc-fixed paraffin-embedded sections and formalin-fixed paraffin-embedded sections)4,6, Western blotting7, and spatial biology (IBEX)10,11. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103163 and 103164).

Application References

(PubMed link indicates BioLegend citation)
  1. Podd BS, et al. 2006. J. Immunol. 176:6532. (FC, CMCD) PubMed
  2. Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC)
  3. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IP)
  4. Simon DI, et al. 2000. J. Clin. Invest. 105:293. (IHC)
  5. Seaman WE. 1983. J. Immunol. 130:1713. (CMCD)
  6. Cornet A, et al. 2001. P. Natl. Acad. Sci. USA 98:13306. (IHC)
  7. Tsuboi S and Fukuda M. 1998. J. Biol. Chem. 273:30680. (WB) PubMed
  8. Liu F, et al. 2012. Blood. 119:3295. PubMed
  9. Pelletier AN, et al. 2012. J. Immunol. 188:5561. PubMed
  10. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  11. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Johnson DC, et al. 2018. Nat Med. 24:1151. PubMed
  2. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  3. Xu X, et al. 2020. Chin Med. 15:33. PubMed
  4. Shakya S, et al. 2020. MethodsX. 7:101027. PubMed
  5. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  6. Hutton C, et al. 2021. Cancer Cell. 39:1227. PubMed
  7. Nederlof R, et al. 2022. Front Immunol. 13:908023. PubMed
  8. Kataru RP, et al. 2021. Sci Signal. 14:. PubMed
  9. Li Z, et al. 2022. Nat Commun. 13:1845. PubMed
  10. J Gautam, X Zhang, Y Yao 2016. Sci Rep. 6:36450. PubMed
  11. Li Y, et al. 2020. Nat Commun. 2.350694444. PubMed
  12. Gabitova-Cornell L, et al. 2020. Cancer Cell. 38(4):567-583.e11. PubMed
  13. Huang Z et al. 2017. Cell metabolism. 26(3):493-508 . PubMed
  14. McGill BE et al. 2018. The Journal of Neuroscience. 38(1):200-219 . PubMed
  15. Hofmann I, et al. 2022. J Pharmacol Exp Ther. Online ahead of print. PubMed
  16. Hulsebus HJ, et al. 2022. Front Immunol. 13:884719. PubMed
  17. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  18. El-Hindi K, et al. 2022. Int J Mol Sci. 23:. PubMed
  19. Qi Z, et al. 2022. Nat Commun. 13:182. PubMed
  20. Ma J, et al. 2020. Adv Sci (Weinh). 7:2000609. PubMed
  21. Sharma GP, et al. 2021. PLoS One. 16:e0259042. PubMed
  22. Zhu H, et al. 2018. Elife. 7:. PubMed
  23. Rodriguez-García A, et al. 2021. Nat Commun. 12:877. PubMed
  24. Tcheng M, et al. 2021. Blood. 137:3518. PubMed
  25. Prado C, et al. 2021. J Neuroinflammation. 18:292. PubMed
  26. Wang M, et al. 2022. Theranostics. 12:4513. PubMed
  27. Adachi Y, et al. 2022. Nat Commun. 13:5117. PubMed
  28. Bauer KM, et al. 2022. JCI Insight. 7:. PubMed
  29. Sepe JJ, et al. 2022. JACC Basic Transl Sci. 7:915. PubMed
  30. Abdala-Valencia H, et al. 2014. Am J Physiol Lung Cell Mol Physiol. 307:482. PubMed
  31. Shao Y, et al. 2019. Diabetes. 68:2131. PubMed
  32. Lee AK, et al. 2020. Radiat Res. 193:305. PubMed
  33. Choi H et al. 2019. Cell Rep. 27(3):806-819 . PubMed
  34. Agelidis A, et al. 2019. Front Immunol. 10:500. PubMed
  35. Neumann AM et al. 2017. PloS one. 12(11):e0187330 . PubMed
  36. Rao E, et al. 2021. Sci Immunol. 6:. PubMed
  37. Saito S, et al. 2020. Nutrients. 12:. PubMed
  38. Liu X, et al. 2020. Nature. . PubMed
  39. Liang W, et al. 2020. Nat Commun. 4.563888889. PubMed
  40. Zhang Q, et al. 2019. PLoS Biol. 17:e3000330. PubMed
  41. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  42. Ohigashi I, et al. 2020. Cell Reports. 29(9):2901-2916.e6.. PubMed
  43. Ihara S, et al. 2022. PLoS Negl Trop Dis. 16:e0010323. PubMed
  44. Talma N, et al. 2021. Aging Cell. 20:e13450. PubMed
  45. Zhao G, et al. 2020. Sci Adv. 6:00. PubMed
  46. Evren E, et al. 2020. Immunity. 54(2):259-275.e7. PubMed
  47. Wosczyna MN, et al. 2021. Cell Stem Cell. 28(7):1323-1334.e8. PubMed
  48. Pan H, et al. 2020. Mol Psychiatry. . PubMed
  49. Wang X, et al. 2021. Front Cell Dev Biol. 632805:9. PubMed
  50. Zhang C, et al. 2020. Cell Metabolism. 31(1):148-161.e5.. PubMed
  51. Lu Y, et al. 2020. Cell. 180(6):1081-1097. PubMed
  52. Meixiong J et al. 2019. Immunity. 50(5):1163-1171 . PubMed
  53. Xiao X, et al. 2019. Cell Discov. 5:2. PubMed
  54. Dai B, et al. 2022. Theranostics. 12:7603. PubMed
  55. Francian A, et al. 2021. J Drug Target. 29:754. PubMed
  56. Johansen AZ, et al. 2022. Pharmaceutics. 14:. PubMed
  57. Rolfes S, et al. 2020. Neurobiol Dis. 144:105024. PubMed
  58. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  59. Han C, et al. 2021. Cell Reports. 34(6):108706. PubMed
  60. Emgård J, et al. 2018. Immunity. 143:419. PubMed
  61. Parada-Kusz M, et al. 2018. Dis Model Mech. 11:. PubMed
  62. Feng Y, et al. 2018. Kidney Dis (Basel). 4:95. PubMed
  63. Wosczyna MN et al. 2019. Cell Rep. 27(7):2029-2035 . PubMed
  64. Plein A, et al. 2018. Nature. 562:223. PubMed
  65. Kobayashi S, et al. 2019. J Immunol. 203:1447. PubMed
  66. Green DP, et al. 2019. Neuron. 101:412. PubMed
  67. Davidson S, et al. 2020. Cell Reports. 31(7):107628. PubMed
  68. Liang Z, et al. 2020. Pain. 161:2089. PubMed
  69. Zhang W, et al. 2021. Cell Prolif. 54:e13058. PubMed
  70. Gui J, et al. 2020. Nat Cancer. 1:603. PubMed
  71. Hore ZL, et al. 2021. Wellcome Open Res. 6:68. PubMed
  72. Dane EL, et al. 2022. Nat Mater. 21:710. PubMed
  73. Yao L, et al. 2021. J Bone Miner Res. 36:1159. PubMed
  74. Koujah L, et al. 2021. Ocul Surf. 21:238. PubMed
  75. Kumari A, et al. 2022. Sci Rep. 12:15273. PubMed
  76. Li P, et al. 2021. Nat Immunol. 22:1107. PubMed
  77. Zhang X, et al. 2022. Cells. 11:. PubMed
  78. Kucinski I, et al. 2020. EMBO J. :e104983. PubMed
  79. Müller A, et al. 2020. J Clin Invest. 5765:130. PubMed
  80. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  81. Barman PK, et al. 2019. J Immunol. 202:2720. PubMed
  82. Lim D, et al. 2018. Front Physiol. 9:47. PubMed
  83. Zein HS, et al. 2022. Sci Rep. 12:4834. PubMed
  84. Luo W, et al. 2022. Front Immunol. 13:816761. PubMed
  85. Kusuyama J, et al. 2021. Cell Metabolism. 33(5):939-956.e8. PubMed
  86. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  87. Wang ECE, et al. 2019. Cell Stem Cell. 24:654. PubMed
  88. Cervera–Carrascon V, et al. 2020. Oncoimmunology. 9:1761229. PubMed
  89. Morimoto A, et al. 2021. Nat Commun. 12:2136. PubMed
  90. Poillet-Perez L, et al. 2020. Nat Cancer. 1:923. PubMed
  91. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  92. Gañán-Gómez I, et al. 2022. Nat Med. . PubMed
  93. Chin AL, et al. 2021. Nat Commun. 12:5138. PubMed
  94. Zhang K, et al. 2014. PLoS Pathog. 10:1004385. PubMed
  95. Mencarelli A, et al. 2016. Sci Rep. 6:30802. PubMed
  96. Lu X, et al. 2016. Nat Commun. 7: 12719. PubMed
  97. Hu J, et al. 2020. Theranostics. 7.154166667. PubMed
  98. Li J, et al. 2020. Elife. 9:00. PubMed
  99. Rosa JM, et al. 2021. British Journal of Pharmacology. . PubMed
  100. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  101. Wan X, et al. 2018. Nature. 560:107. PubMed
  102. Al–Zaher AA, et al. 2018. Mol Ther Oncolytics. 0.376388889. PubMed
  103. Hepler C et al. 2018. eLife. 7 pii: e39636. PubMed
  104. Goldfarb Y, et al. 2021. J Exp Med. 218:. PubMed
  105. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  106. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
  107. Brigas HC, et al. 2021. Cell Reports. 36(9):109574. PubMed
  108. Zhu H, et al. 2021. Cell Metabolism. :. PubMed
  109. Nguyen PT, et al. 2020. Cell. 182(2):388-403.e15. PubMed
  110. Liu CY, et al. 2020. Cell Rep. 33:108275. PubMed
  111. Cai Y, et al. 2019. Cell Rep. 27:3034. PubMed
  112. Crowell PD et al. 2019. Cell Rep. 28(6):1499-1510 . PubMed
  113. Maetzig T, et al. 2017. Mol Ther. 25:606. PubMed
  114. Burr ML, et al. 2019. Cancer Cell. 36:385. PubMed
  115. Wang F, et al. 2019. MAbs. 12:1685350. PubMed
  116. Ji DX, et al. 2019. Nat Microbiol. 1.644444444. PubMed
  117. Liu S, et al. 2020. Cell Host & Microbe. 26(6):779-794.e8.. PubMed
  118. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  119. Ruan C, et al. 2020. Brain Behav Immun. 83:180. PubMed
  120. Sefik E, et al. 2021. Nat Biotechnol. . PubMed
  121. Watanabe Y, et al. 2020. J Biol Chem. 295:17632. PubMed
  122. Engler AE, et al. 2020. Cell Reports. 33(13):108553. PubMed
  123. Coronel MM, et al. 2020. Sci Adv. 6:eaba5573. PubMed
  124. Pundir P, et al. 2020. Cell Host & Microbe. 26(1):114-122. PubMed
  125. Gastelum‐Aviña P et al. 2016. Journal of immunological methods. 438:42-50 . PubMed
  126. Zhou J, et al. 2019. Nat Commun. 10:2427. PubMed
  127. Yu X, et al. 2019. Nat Commun. 10:574. PubMed
  128. Su S et al. 2018. Cell. 175(2):442-457 . PubMed
  129. Milner MT, et al. 2022. STAR Protoc. 3:101295. PubMed
  130. Zhang X, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  131. Xiao L, et al. 2021. Clin Cancer Res. 27:4338. PubMed
  132. Kotas ME, et al. 2022. JCI Insight. :. PubMed
  133. Rashid MH, et al. 2021. Oncol Rep. 45:1171. PubMed
  134. Jiang Y, et al. 2021. Cell Death Differ. 28:3009. PubMed
  135. Agelidis A, et al. 2021. JCI Insight. 6: . PubMed
  136. Monaghan KL, et al. 2020. J Vis Exp. . PubMed
  137. Yamakawa D, et al. 2021. Cell Reports. 34(10):108817. PubMed
  138. Galle-Treger L, et al. 2016. Nat Commun. 7:13202. PubMed
  139. Wang Z et al. 2018. Immunity. 49(1):80-92 . PubMed
  140. Sarvi S et al. 2018. Cell chemical biology. 25(12):1456-1469 . PubMed
  141. Hu Y, et al. 2021. Cell Death Dis. 12:743. PubMed
  142. Minhas PS, et al. 2021. Nature. 590:122. PubMed
  143. Zhang X, et al. 2021. Mol Cancer Res. 19:1076. PubMed
  144. Liu S, et al. 2022. J Neuroinflammation. 19:35. PubMed
  145. Xiao Y, et al. 2022. Nat Commun. 13:758. PubMed
  146. Ali S, et al. 2021. PLoS One. 16:e0246646. PubMed
  147. Yang Z, et al. 2021. Nat Commun. 12:4852. PubMed
  148. Long JT, et al. 2022. Elife. 11:. PubMed
  149. Bravo-Caparrós I, et al. 2020. FASEB J. 34:5951. PubMed
  150. Zhang P, et al. 2022. Nat Commun. 13:1588. PubMed
  151. Sirvinskas D, et al. 2022. iScience. 25:104202. PubMed
  152. Ito K, et al. 2014. Proc Natl Acad Sci U S A. 111:3080. PubMed
  153. Saunders L, et al. 2015. Sci Transl Med. 7: 302ra136. PubMed
  154. Jiang Q, et al. 2020. JCI Insight. 5:00. PubMed
  155. Hasegawa T, et al. 2020. Sci Rep. 10:13480. PubMed
  156. Johnson DC, et al. 2020. Cell Death Dis. 0.894444444. PubMed
  157. Li CM, et al. 2020. Cell Reports. 33(13):108566. PubMed
  158. Zhang L, et al. 2021. iScience. 24(9):102942. PubMed
  159. Qi F, et al. 2019. Front Microbiol. 2.140277778. PubMed
  160. Yu JM, et al. 2019. Nat Commun. 4.388888889. PubMed
  161. Li Z, et al. 2022. Nat Commun. 13:6321. PubMed
  162. Hou Y, et al. 2021. Sci Transl Med. 13:. PubMed
  163. Xu G, et al. 2022. Front Pharmacol. 13:896601. PubMed
  164. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  165. Song J, et al. 2021. Am J Physiol Heart Circ Physiol. 320:H323. PubMed
  166. Zeis P, et al. 2020. Immunity. 53:775. PubMed
  167. Ben-Yehuda H, et al. 2021. Mol Neurodegener. 16:39. PubMed
  168. Kim H, et al. 2020. Biomed Rep. 0.589583333. PubMed
  169. Ovadya Y, et al. 2018. Nat Commun. 9:5435. PubMed
  170. Zheng B, et al. 2021. Bioact Mater. 6:3879. PubMed
  171. Ferrer-Font L, et al. 2020. Elife. 9:. PubMed
  172. Sakai H, et al. 2022. iScience. 25:103928. PubMed
  173. Walker MT, et al. 2021. Front. Allergy. 2:. PubMed
  174. Kataru RP, et al. 2022. Front Aging. 3:864860. PubMed
  175. Pan Y, et al. 2021. Br J Pharmacol. 178:4907. PubMed
  176. Tomimatsu M, et al. 2022. Sci Rep. 12:16656. PubMed
  177. Chen M, et al. 2019. Cell Stem Cell. 25:501. PubMed
  178. Sema Kurtulus et al. 2018. Immunity. 50(1):181-194 . PubMed
  179. Liu L et al. 2018. Cell stem cell. 23(4):544-556 . PubMed
  180. Zhao N, et al. 2018. J Clin Invest. 26:84. PubMed
  181. Hameed H, et al. 2022. Int J Mol Sci. 23:. PubMed
  182. Ding R, et al. 2022. J Neuroinflammation. 19:137. PubMed
  183. Liu R, et al. 2020. Eur J Vasc Endovasc Surg. 60:254. PubMed
  184. Fan ZP, et al. 2021. Front Immunol. 12:743354. PubMed
  185. Okada R, et al. 2021. EBioMedicine. 67:103345. PubMed
  186. Ding L et al. 2018. Cell reports. 25(11):2972-2980 . PubMed
  187. Hao T, et al. 2019. Nat Commun. 10:3665. PubMed
  188. Zegarra‐Ruiz DF et al. 2018. Cell host & microbe. 25(1):113-127 . PubMed
  189. Chao Y, et al. 2020. Sci Adv. 6:eaaz4204. PubMed
  190. Kataru RP, et al. 2019. Cancer Immunol Res. 7:1345. PubMed
  191. Krivtsov AV, et al. 2020. Cancer Cell. 36(6):660-673.e11.. PubMed
  192. Hu X, et al. 2020. Neoplasia. 1.290972222. PubMed
  193. Chen L, et al. 2021. Theranostics. 11:6668. PubMed
  194. Sugita Y, et al. 2021. Oncol Rep. 45:. PubMed
  195. Banskota S, et al. 2021. Inflamm Bowel Dis. 27:914. PubMed
  196. Ruan Y, et al. 2022. Exp Ther Med. 23:47. PubMed
  197. Wang R, et al. 2022. J Immunother Cancer. 10:. PubMed
  198. Liao X, et al. 2022. JCI Insight. 7:. PubMed
  199. Kelley WJ, et al. 2022. JCI Insight. :. PubMed
  200. Cerina M, et al. 2017. Brain Behav Immun. 59:103-117. PubMed
  201. Simoes Eugénio M, et al. 2020. Cancers (Basel). 12:00. PubMed
  202. Tr änkner D, et al. 2019. Cell Rep. 29:791. PubMed
  203. Lee C, et al. 2020. Front Immunol. 11:77. PubMed
  204. Eckert EC, et al. 2020. Mol Ther Oncolytics. 0.710416667. PubMed
  205. Poillet–Perez L, et al. 2018. Nature. 563:569. PubMed
  206. Padhye A, et al. 2019. Sci Rep. 9:4819. PubMed
  207. Zhou Y, et al. 2022. Theranostics. 12:5488. PubMed
  208. Sheng D, et al. 2022. J Immunother Cancer. 10:. PubMed
  209. El-Obeid A, et al. 2021. Exp Ther Med. 22:1081. PubMed
  210. Sharma R, et al. 2021. J Neuroinflammation. 72:18. PubMed
  211. Watanabe Y, et al. 2020. J Biol Chem. . PubMed
  212. Sheng J, et al. 2021. eLife. 10:00. PubMed
  213. Le TM et al. 2018. Journal of neurochemistry. 145(2):139-153 . PubMed
  214. Lee EKS, et al. 2018. Cell Host Microbe. 23:121. PubMed
  215. Shao Y, et al. 2019. Stem Cells. 37:1331. PubMed
  216. Krotova K, et al. 2019. Mol Ther Oncolytics. 15:166. PubMed
  217. Gupta R, et al. 2020. Cell Stem Cell. 26:527. PubMed
  218. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  219. Li M, et al. 2020. Nat Commun. 4051:11. PubMed
  220. Ma Y, et al. 2020. Front Immunol. 11:586685. PubMed
  221. Pessoa Rodrigues C, et al. 2020. Sci Adv. 6:eaaz4815. PubMed
  222. Guarnerio J, et al. 2018. Nat Commun. 9:66. PubMed
  223. Wolf Y, et al. 2019. Cell. 179:219. PubMed
  224. Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed
  225. Wang H, et al. 2022. J Cancer. 13:2126. PubMed
  226. Zhang SJ, et al. 2021. Adv Sci (Weinh). 8:2003410. PubMed
  227. Zhang L, et al. 2021. Mol Ther. 29:744. PubMed
  228. Andreata F, et al. 2021. STAR Protoc. 2:100831. PubMed
  229. Ichinose M, et al. 2021. Sci Rep. 7200:11. PubMed
  230. Zhang B, et al. 2021. Front Neurol. 607370:12. PubMed
  231. Dingler FA, et al. 2020. Mol Cell. . PubMed
  232. Wan Y, et al. 2020. Cell Rep. 33:108346. PubMed
  233. Badgujar DC, et al. 2020. PLoS Pathog. 16:e1009016. PubMed
RRID
AB_312972 (BioLegend Cat. No. 103107)
AB_312973 (BioLegend Cat. No. 103108)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4, TCR, CD22, Thy-1
Cell Type
B cells, Dendritic cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID
UniProt
View information about CD45 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD45 Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD45 30-F11 FC
Biotin anti-mouse CD45 30-F11 FC
FITC anti-mouse CD45 30-F11 FC
PE anti-mouse CD45 30-F11 FC
PE/Cyanine5 anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 30-F11 FC, IHC-F, CyTOF®, IP, CMCD, IHC, WB
PE/Cyanine7 anti-mouse CD45 30-F11 FC
APC/Cyanine7 anti-mouse CD45 30-F11 FC
Alexa Fluor® 488 anti-mouse CD45 30-F11 FC, SB
Alexa Fluor® 647 anti-mouse CD45 30-F11 FC, ICC, IHC, 3D IHC, SB
Pacific Blue™ anti-mouse CD45 30-F11 FC
Alexa Fluor® 700 anti-mouse CD45 30-F11 FC, SB
PerCP/Cyanine5.5 anti-mouse CD45 30-F11 FC
PerCP anti-mouse CD45 30-F11 FC
Alexa Fluor® 594 anti-mouse CD45 30-F11 IHC-F, FC, 3D IHC
Brilliant Violet 421™ anti-mouse CD45 30-F11 FC, SB
Brilliant Violet 570™ anti-mouse CD45 30-F11 FC
Brilliant Violet 510™ anti-mouse CD45 30-F11 FC
Brilliant Violet 605™ anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 (Maxpar® Ready) 30-F11 FC, CyTOF®
PE/Dazzle™ 594 anti-mouse CD45 30-F11 FC
Brilliant Violet 711™ anti-mouse CD45 30-F11 FC
Brilliant Violet 785™ anti-mouse CD45 30-F11 FC
Brilliant Violet 650™ anti-mouse CD45 30-F11 FC
APC/Fire™ 750 anti-mouse CD45 30-F11 FC
Brilliant Violet 750™ anti-mouse CD45 30-F11 FC
TotalSeq™-A0096 anti-mouse CD45 30-F11 PG
TotalSeq™-B0096 anti-mouse CD45 30-F11 PG
Ultra-LEAF™ Purified anti-mouse CD45 30-F11 FC, CyTOF®, IP, CMCD, IHC, WB
Spark Blue™ 550 anti-mouse CD45 30-F11 FC
Spark NIR™ 685 anti-mouse CD45 30-F11 FC
TotalSeq™-C0096 anti-mouse CD45 30-F11 PG
Spark YG™ 570 anti-mouse CD45 30-F11 IHC-F
PE/Fire™ 640 anti-mouse CD45 30-F11 FC
APC/Fire™ 810 anti-mouse CD45 30-F11 FC
PE/Fire™ 700 anti-mouse CD45 30-F11 FC
Spark Violet™ 538 anti-mouse CD45 30-F11 FC
Spark YG™ 593 anti-mouse CD45 30-F11 FC
Spark Blue™ 574 anti-mouse CD45 Antibody 30-F11 FC
Go To Top Version: 2    Revision Date: 05/14/2013

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

  • APC anti-mouse CD45

  • Biotin anti-mouse CD45

  • FITC anti-mouse CD45

  • PE anti-mouse CD45

  • PE/Cyanine5 anti-mouse CD45

  • Purified anti-mouse CD45

  • PE/Cyanine7 anti-mouse CD45

  • APC/Cyanine7 anti-mouse CD45

  • Alexa Fluor® 488 anti-mouse CD45

  • Alexa Fluor® 647 anti-mouse CD45

  • Pacific Blue™ anti-mouse CD45

  • Alexa Fluor® 700 anti-mouse CD45

  • PerCP/Cyanine5.5 anti-mouse CD45

  • PerCP anti-mouse CD45

  • Alexa Fluor® 594 anti-mouse CD45

  • Brilliant Violet 421™ anti-mouse CD45

  • Brilliant Violet 570™ anti-mouse CD45

  • Brilliant Violet 510™ anti-mouse CD45

  • Brilliant Violet 605™ anti-mouse CD45

  • Purified anti-mouse CD45 (Maxpar® Ready)

  • PE/Dazzle™ 594 anti-mouse CD45

  • Brilliant Violet 711™ anti-mouse CD45

  • Brilliant Violet 785™ anti-mouse CD45

  • Brilliant Violet 650™ anti-mouse CD45

  • APC/Fire™ 750 anti-mouse CD45

  • Brilliant Violet 750™ anti-mouse CD45

  • TotalSeq™-A0096 anti-mouse CD45

  • TotalSeq™-B0096 anti-mouse CD45

  • Ultra-LEAF™ Purified anti-mouse CD45

  • Spark Blue™ 550 anti-mouse CD45

  • Spark NIR™ 685 anti-mouse CD45

  • TotalSeq™-C0096 anti-mouse CD45

  • Spark YG™ 570 anti-mouse CD45

  • PE/Fire™ 640 anti-mouse CD45

  • APC/Fire™ 810 anti-mouse CD45

  • PE/Fire™ 700 anti-mouse CD45

  • Spark Violet™ 538 anti-mouse CD45

  • Spark YG™ 593 anti-mouse CD45

  • Spark Blue™ 574 anti-mouse CD45 Antibody

ProductsHere

Login/Register
Remember me
Forgot your password? Reset Password
Request an Account